Medicine and Dentistry
Patient
100%
Exon
67%
Epidermal Growth Factor Receptor
17%
Recurrence Free Survival
17%
Lung Adenocarcinoma
14%
Epidermal Growth Factor Receptor
14%
Prognostic Factor
10%
Recurrent Disease
10%
Overall Survival
10%
Surgery
7%
Pneumonectomy
3%
Survival Rate
3%
Multivariate Analysis
3%
Adipiodone
3%
Incidence
3%
Immunology and Microbiology
Exon
67%
Wild Type
17%
Recurrence Free Survival
17%
Mutation
14%
Lung
14%
Overall Survival
10%
Survival Rate
3%
Incidence
3%
Nursing and Health Professions
Wild Type
17%
Recurrence Free Survival
17%
Epidermal Growth Factor Receptor
17%
Lung Adenocarcinoma
14%
Overall Survival
10%
Recurrent Disease
10%
Surgery
7%
Multivariate Analysis
3%
Survival Rate
3%
Prognosis
3%
Procedures
3%
Incidence
3%
Adipiodone
3%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
17%
Recurrence Free Survival
17%
Lung Adenocarcinoma
14%
Overall Survival
10%
Recurrent Disease
10%
Prognosis
3%
Survival Rate
3%
Adipiodone
3%
Incidence
3%